Drawing for JOHNS HOPKINS INHEALTH

USPTO serial 85703873

JOHNS HOPKINS INHEALTH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WHITE, RICHARD F
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with JOHNS HOPKINS INHEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura T. Geyer

Laura T. Geyer Vorys, Sater, Seymour and Pease LLPP.O. Box 2255IPLaw@VorysColumbus, OH 43216-2255

Goods and services

ClassDescriptionStatusFirst use
009Computer software and computer software development tools for the intelligent use and provision of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Computer software platforms for the intelligent use and provision of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Pre-recorded electronic and digital media featuring content in the field of intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectoriesACTIVE—
016Print publications in the nature of newsletters, reports, journals, books, guides, manuals, and instructional, educational, and teaching materials in the field of intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectoriesACTIVE—
035Business consultation, strategic planning, and advisory services in the field of intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Public advocacy to promote awareness of intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Public policy consultancy and research services in the field of intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Promoting collaboration within the scientific, research, medical, government, and health care provider communities to achieve advances in the field of intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Business consulting services in the field of healthcare and hospital management through the intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectoriesACTIVE—
041Educational services, namely, conducting classes, conferences, courses, seminars, training, and workshops in the field of intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Providing online publications in the nature of newsletters, reports, journals, books, guides, manuals, and instructional, educational, and teaching materials in the field of intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectoriesACTIVE—
042Medical and scientific research in the field of intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Research and development in the field of intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Scientific study and research in the field of intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Providing on-line, non-downloadable software and information tools for the intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Software as a service (SAAS) for the intelligent use and provision of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories. Platform as a service (PAAS) featuring computer software platforms for the intelligent use and provision of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Design and development of software and hardware for the intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Providing information in the field of technology and software development related to the intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectoriesACTIVE—
044Health care; medical services; hospital services; individualized health care and medical services; providing health care and medical services through the intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Consulting services in the field of health and health care; consulting services in the field of health and health care, namely, the intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Providing an on-line searchable database featuring information related to the intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Providing health and health care information related to the intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Providing medical information related to the intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories; Medical testing and screening for diagnostic or treatment purposes; individualized medical testing and screening for diagnostic or treatment purposes; providing medical testing and screening for diagnostic or treatment purposes through the intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectoriesACTIVE—
045Online social networking services in the field of intelligent use of health data and information to individualize health promotion, disease prevention, diagnosis, detection, and treatment, and methods to analyze, collect, define, display, manage, measure, monitor, share, track, and communicate health care data, health state, and health trajectories provided via a websiteACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 27, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 27, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 11, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 11, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 3, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 2, 2015EX5GSOU EXTENSION 5 GRANTED—
Nov 19, 2015EXT5SOU EXTENSION 5 FILED—
Nov 19, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 4, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 3, 2015EX4GSOU EXTENSION 4 GRANTED—
May 31, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 19, 2015EXT4SOU EXTENSION 4 FILED—
May 19, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 27, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 26, 2014EX3GSOU EXTENSION 3 GRANTED—
Nov 18, 2014EXT3SOU EXTENSION 3 FILED—
Nov 18, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 24, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 23, 2014EX2GSOU EXTENSION 2 GRANTED—
May 21, 2014EXT2SOU EXTENSION 2 FILED—
May 21, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 22, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 21, 2014EX1GSOU EXTENSION 1 GRANTED—
Jan 17, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 13, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 21, 2013EXT1SOU EXTENSION 1 FILED—
Nov 21, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 21, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 26, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 26, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 6, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 20, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 20, 2013ALIEASSIGNED TO LIE—
Feb 6, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 5, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 4, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 4, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 11, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2012DOCKASSIGNED TO EXAMINER—
Aug 23, 2012MPMKNOTICE OF PSEUDO MARK MAILED—
Aug 22, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 18, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance